Bisphosphonates stimulate basic fibroblast growth factor production and bone marrow osteoblastogenesis. New hypotheses on their mechanism of action;I bisfosfonati stimolano la produzione di 'basic fibroblast growth factor' e la formazione dei precursori midollari degli osteoblasti: Nuove acquisizioni sul meccanismo di azione

Minerva Medica

Volumn 89, Issue 7-8, 1998, Pages 249-258

  Giuliani, N ^a  

^a Ist Clin Medica Gen Terap Medica   (Italy)

Author keywords

Alendronate; Bisphosphonates; Colony forming units, fibroblastic; Eldronate, disodium; Fibroblast growth factor, basic; Osteoblasts

Indexed keywords

ALENDRONIC ACID; BASIC FIBROBLAST GROWTH FACTOR; BISPHOSPHONIC ACID DERIVATIVE; ETIDRONIC ACID;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; COLONY FORMING UNIT F; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST;

ALENDRONATE; ANIMALS; BONE MARROW; DOSE-RESPONSE RELATIONSHIP, DRUG; ETIDRONIC ACID; FIBROBLAST GROWTH FACTOR 2; HUMANS; MICE; OSTEOBLASTS; STEM CELLS;

EID: 0031759175     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Adami S, Passen M, Ortolani S, Broggini M, Carratelli L, Caruso I et al. Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis. Bone 1995;17:383-90.
2. Giannini S, D'Angelo A, Malvasi L, Castrignano R, Pati T, Tronca R et al. Effects of one-year cyclical treatment with clodronate on postmenopausal bone loss. Bone 1993;14:137-41.
3. Liberman UA, Weiss SR, Bröll J, Minne HW, Quan H, Bell NH et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 1995;333:1437-43.
4. Passeri M, Baroni MC, Pedrazzoni M, Pioli G, Barbagallo M, Costi D et al. Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosis. Bone Miner 1991;15:237-47.